University of California, San Francisco: Insulin Resistance trials
The registry lists 17 Insulin Resistance studies with University of California, San Francisco as lead sponsor. 1 are open to participants now and 2 have results posted.
Phase 1 2Phase 2 3Phase 4 2No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Gauging Outcomes of Total Milk Ingestion on Lipid and gControlRecruitingNCT07087184Not applicable
- Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) TrialTerminatedNCT03380091Phase 4Results posted
- Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetesCompletedNCT02023918Phase 2Results posted
- Glucose Evaluation Through Continuous Glucose Monitors in Polycystic Ovary SyndromeActive, not recruitingNCT06050265Not applicable
- Metabolic Health Improvement Program: Effects of a Workplace Sugary Beverages Sales Ban and Motivational CounselingCompletedNCT05972109Not applicable
- Tissue-specific Insulin Resistance in Obstructive Sleep Apnea: Role of HypoxiaCompletedNCT03695315
- Study of Time-restricted Eating on Weight Loss.CompletedNCT03393195Not applicable
- PCOS & Insulin Resistance Exercise StudyActive, not recruitingNCT02303470Not applicable
- Cardiovascular Effects of Metformin on ObesityWithdrawnNCT01910246Phase 4
- Insulin Resistance in HCV InfectionActive, not recruitingNCT01858012
- The Effects of Sedentarism on Vascular Function, Inflammation, and Insulin ResistanceTerminatedNCT01412216Phase 2
- Effects of Sleep Duration and Architecture on Insulin SensitivityCompletedNCT01396941Not applicable
- Mechanism of Insulin-Resistant in Lean Non-DiabeticsCompletedNCT00970099Phase 1
- Chromium and Insulin ResistanceCompletedNCT00846248Not applicable
- Alpha Lipoic Acid and Insulin ResistanceCompletedNCT00845156Not applicable
- Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic SyndromeWithdrawnNCT00654667Phase 2
- Alpha Lipoic Acid and Polycystic Ovary SyndromeCompletedNCT00505427Phase 1